Eccogene
PrivateLast Round
Strategic
Nov 9, 2023
Est. Valuation
$498M
Total Funding Raised
$238.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Eccogene is a clinical-stage biopharmaceutical company that develops next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eccogene Comparables
Compare Eccogene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regor Therapeutics Group | 86% | |
| Kailera Therapeutics | 84% | |
| Structure Therapeutics | 84% | |
Eccogene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 9, 2023 | ||||
| Series B | Jun 11, 2023 | ||||
| Series A Extension | Dec 22, 2020 | ||||
| Series A | Sep 7, 2018 |
Eccogene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Alliance Capital | Series B |
| TF Capital | Series A |
| 健壹资本 | Series A |
| Huajin Capital | Series B |
| Huagai Capital | Series A Extension |
| Qingsong Capital | Series B, Series A Extension |
| Oriza Seed Venture Capital | Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 52% MoM.
- Apr 8, 2026
Job posting indicates company is pre-IPO.
Eccogene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eccogene's valuation, stock price, and market status.